Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer.

CONCLUSION: We observed that women who took certain forms of an AH medication during the year following a diagnosis of ovarian cancer were thereafter at a relatively reduced risk of dying from their disease. However, the potential for residual confounding by disease severity argues for a cautious interpretation.
PMID: 31178150 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - June 5, 2019 Category: Cancer & Oncology Authors: Harding BN, Delaney JA, Urban RR, Weiss NS Tags: Gynecol Oncol Source Type: research